Xiaolong Liu Selected Research

Breast Neoplasms (Breast Cancer)

1/2023	Glutathione-Exhausting Nanoprobes for NIR-II Fluorescence Imaging-Guided Surgery and Boosting Radiation Therapy Efficacy via Ferroptosis in Breast Cancer.
1/2022	Nanoplatform Self-Assembly from Small Molecules of Porphyrin Derivatives for NIR-II Fluorescence Imaging Guided Photothermal-Immunotherapy.
5/2019	[Expression of NUF2 in breast cancer and its clinical significance].
1/2019	Development of Effective Therapeutics Targeting HER3 for Cancer Treatment.
1/2018	TGF-α Overexpression in Breast Cancer Bone Metastasis and Primary Lesions and TGF-α Enhancement of Expression of Procancer Metastasis Cytokines in Bone Marrow Mesenchymal Stem Cells.
7/2013	Increased expression of mitotic arrest deficient-like 1 (MAD1L1) is associated with poor prognosis and insensitive to Taxol treatment in breast cancer.
6/2013	Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaolong Liu Research Topics

Disease

195	Neoplasms (Cancer) 05/2024 - 01/2010
69	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 06/2014
31	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2014
20	Hypoxia (Hypoxemia) 05/2024 - 01/2017
17	Carcinogenesis 10/2023 - 02/2013
11	Liver Neoplasms (Liver Cancer) 08/2023 - 08/2014
9	Inflammation (Inflammations) 01/2024 - 08/2015
8	Infections 01/2023 - 04/2007
7	Thrombosis (Thrombus) 05/2024 - 11/2014
7	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 12/2017
7	Breast Neoplasms (Breast Cancer) 01/2023 - 06/2013
5	Wounds and Injuries (Trauma) 01/2024 - 01/2021
5	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 04/2018
4	Bites and Stings (Sting) 04/2024 - 01/2021
4	Lung Neoplasms (Lung Cancer) 01/2024 - 06/2012
4	Liver Diseases (Liver Disease) 01/2024 - 01/2020
4	Necrosis 09/2023 - 04/2015
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 07/2018
4	Pain (Aches) 06/2022 - 07/2017
4	Starvation 01/2022 - 01/2017
3	Renal Cell Carcinoma (Grawitz Tumor) 05/2024 - 01/2020
3	Aortic Coarctation 11/2023 - 01/2020
3	Lymphatic Metastasis 01/2023 - 01/2019
3	Carcinoma (Carcinomatosis) 01/2023 - 03/2014
3	Aneurysm (Aneurysms) 11/2022 - 09/2012
3	Sepsis (Septicemia) 01/2022 - 01/2021
3	Hepatitis B 08/2021 - 11/2014
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2020 - 01/2013
3	Type 2 Diabetes Mellitus (MODY) 11/2019 - 05/2011

Drug/Important Bio-Agent (IBA)

33	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2013
32	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2012
17	Therapeutic UsesIBA 08/2023 - 09/2017
14	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2022 - 04/2015
11	MicroRNAs (MicroRNA)IBA 03/2024 - 06/2012
11	CytokinesIBA 09/2023 - 02/2015
10	Messenger RNA (mRNA)IBA 01/2023 - 06/2012
9	AntigensIBA 01/2022 - 04/2007
8	Immune Checkpoint InhibitorsIBA 02/2024 - 07/2020
8	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 04/2015
8	PolymersIBA 01/2023 - 01/2016
8	Silicon Dioxide (Silica)FDA LinkGeneric 01/2023 - 01/2015
8	Photosensitizing Agents (Photosensitizers)IBA 11/2022 - 04/2015
7	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2017
7	LipidsIBA 10/2023 - 12/2007
7	AcidsIBA 01/2023 - 01/2017
6	Oxygen (Dioxygen)IBA 05/2024 - 03/2019
6	Long Noncoding RNAIBA 10/2023 - 09/2015
6	Small Interfering RNA (siRNA)IBA 01/2023 - 02/2016
6	EnzymesIBA 01/2023 - 09/2017
5	VaccinesIBA 01/2024 - 12/2021
5	Fatty Acids (Saturated Fatty Acids)IBA 08/2023 - 01/2021
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2012
5	Capsules (Microcapsules)IBA 01/2023 - 11/2014
5	Glutathione (Reduced Glutathione)IBA 01/2023 - 10/2017
4	Cancer VaccinesIBA 04/2024 - 01/2020
4	Peptides (Polypeptides)IBA 04/2024 - 01/2019
4	Circular RNAIBA 03/2024 - 01/2019
4	HydrogelsIBA 01/2024 - 01/2019
4	CatalaseIBA 01/2024 - 07/2020
4	RNA (Ribonucleic Acid)IBA 11/2023 - 06/2018
4	Cell-Free Nucleic AcidsIBA 10/2023 - 01/2022
4	GlypicansIBA 09/2023 - 06/2014
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2017
4	LigandsIBA 01/2023 - 01/2019
4	UbiquitinIBA 01/2023 - 01/2020
4	phytochlorinIBA 11/2022 - 04/2015
4	AntibodiesIBA 01/2022 - 04/2007
4	IonsIBA 01/2022 - 08/2018
4	Sorafenib (BAY 43-9006)FDA Link 07/2021 - 07/2016
4	Carrier Proteins (Binding Protein)IBA 01/2021 - 07/2016
4	AQ4NIBA 01/2019 - 01/2017
4	polydopamineIBA 05/2016 - 03/2015
3	NanovaccinesIBA 04/2024 - 03/2021
3	Indicators and Reagents (Reagents)IBA 01/2024 - 02/2019
3	AlbuminsIBA 01/2024 - 08/2021
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2023 - 08/2021
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 07/2013
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023 - 01/2019
3	InterferonsIBA 01/2023 - 01/2021
3	CateninsIBA 01/2023 - 01/2017
3	AntioxidantsIBA 12/2022 - 01/2020
3	DisulfidesIBA 11/2022 - 10/2017
3	Hyaluronic Acid (Hyaluronan)IBA 11/2022 - 01/2020
3	LipopolysaccharidesIBA 01/2022 - 08/2015
3	MetalsIBA 11/2019 - 01/2018
3	ProdrugsIBA 01/2019 - 01/2017
3	MicellesIBA 10/2017 - 01/2016
3	Ferrosoferric Oxide (Magnetite)FDA Link 01/2017 - 05/2016
2	tetracarboxyphenylporphineIBA 05/2024 - 01/2020

Therapy/Procedure

63	Therapeutics 05/2024 - 08/2014
34	Immunotherapy 05/2024 - 01/2016
21	Drug Therapy (Chemotherapy) 01/2024 - 01/2015
19	Photothermal Therapy 01/2022 - 06/2014
17	Lasers (Laser) 11/2022 - 01/2013
16	Precision Medicine 11/2021 - 06/2014
15	Photochemotherapy (Photodynamic Therapy) 11/2022 - 04/2015
7	Transplantation 01/2023 - 09/2015
5	Hepatectomy 01/2023 - 01/2014
3	Intravenous Injections 01/2023 - 01/2019